Loomis, Sayles & Company’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $868M | Buy |
|
|||||
|
2025
Q1 | $860M | Buy |
|
|||||
|
2024
Q4 | $995M | Buy |
|
|||||
|
2024
Q3 | $1.03B | Sell |
|
|||||
|
2024
Q2 | $1.27B | Buy |
|
|||||
|
2024
Q1 | $1.14B | Sell |
|
|||||
|
2023
Q4 | $931M | Sell |
|
|||||
|
2023
Q3 | $827M | Sell |
|
|||||
|
2023
Q2 | $768M | Sell |
|
|||||
|
2023
Q1 | $776M | Sell |
|
|||||
|
2022
Q4 | $674M | Sell |
|
|||||
|
2022
Q3 | $516M | Sell |
|
|||||
|
2022
Q2 | $592M | Sell |
|
|||||
|
2022
Q1 | $656M | Sell |
|
|||||
|
2021
Q4 | $690M | Sell |
|
|||||
|
2021
Q3 | $618M | Buy |
|
|||||
|
2021
Q2 | $536M | Sell |
|
|||||
|
2021
Q1 | $450M | Sell |
|
|||||
|
2020
Q4 | $477M | Sell |
|
|||||
|
2020
Q3 | $505M | Sell |
|
|||||
|
2020
Q2 | $482M | Sell |
|
|||||
|
2020
Q1 | $989M | Sell |
|
|||||
|
2019
Q4 | $1.26B | Buy |
|
|||||
|
2019
Q3 | $1.09B | Buy |
|
|||||
|
2019
Q2 | $1.07B | Sell |
|
|||||
|
2019
Q1 | $1.09B | Buy |
|
|||||
|
2018
Q4 | $955M | Sell |
|
|||||
|
2018
Q3 | $1.02B | Buy |
|
|||||
|
2018
Q2 | $982M | Sell |
|
|||||
|
2018
Q1 | $1.08B | Buy |
|
|||||
|
2017
Q4 | $1.11B | Buy |
|
|||||
|
2017
Q3 | $988M | Buy |
|
|||||
|
2017
Q2 | $860M | Buy |
|
|||||
|
2017
Q1 | $651M | Sell |
|
|||||
|
2016
Q4 | $683M | Buy |
|
|||||
|
2016
Q3 | $632M | Buy |
|
|||||
|
2016
Q2 | $637M | Buy |
|
|||||
|
2016
Q1 | $604M | Buy |
|
|||||
|
2015
Q4 | $595M | Buy |
|
|||||
|
2015
Q3 | $531M | Buy |
|
|||||
|
2015
Q2 | $510M | Buy |
|
|||||
|
2015
Q1 | $422M | Buy |
|
|||||
|
2014
Q4 | $279M | Buy |
|
|||||
|
2014
Q3 | $223M | Buy |
|
|||||
|
2014
Q2 | $193M | Buy |
|
|||||
|
2014
Q1 | $178M | Buy |
|